tiprankstipranks
Trending News
More News >
Inmune Bio (INMB)
:INMB
US Market
Advertisement

Inmune Bio (INMB) Technical Analysis

Compare
873 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Inmune Bio’s (INMB) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Inmune Bio is a Sell.
Inmune Bio’s (INMB) 20-Day exponential moving average is 1.59, while Inmune Bio’s (INMB) share price is $1.92, making it a Buy.
Inmune Bio’s (INMB) 50-Day exponential moving average is 1.84, while Inmune Bio’s (INMB) share price is $1.92, making it a Sell.

Inmune Bio (INMB) Pivot Points

Nov 27, 2025, 08:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.41
1.43
1.48
1.50
1.55
1.57
1.62
Fibonacci
1.43
1.46
1.48
1.50
1.53
1.55
1.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Inmune Bio (INMB) Moving Averages

Nov 27, 2025, 08:46 PM
Period
Simple
Exponential
MA5
1.53Buy
1.55Buy
MA10
1.50Buy
1.54Buy
MA20
1.58Buy
1.59Buy
MA50
1.80Sell
1.84Sell
MA100
2.07Sell
2.54Sell
MA200
4.72Sell
4.27Sell
Inmune Bio’s (INMB) 10-Day exponential moving average is 1.54, while Inmune Bio’s (INMB) share price is $1.92, making it a Buy.
Inmune Bio’s (INMB) 100-Day exponential moving average is 2.54, while Inmune Bio’s (INMB) share price is $1.92, making it a Sell.
Inmune Bio’s (INMB) stock price is $1.92 and Inmune Bio’s (INMB) 50-day simple moving average is 1.80, creating a Sell signal.
Inmune Bio’s (INMB) stock price is $1.92 and Inmune Bio’s (INMB) 100-day simple moving average is 2.07, creating a Sell signal.
Inmune Bio’s (INMB) stock price is $1.92 and Inmune Bio’s (INMB) 200-day simple moving average is 4.72, creating a Sell signal.

Inmune Bio (INMB) Technical Indicators

Nov 27, 2025, 08:46 PM
Name
Value
Implied Action
RSI (14)
50.82
Neutral
STOCH (9,6)
60.28
Neutral
STOCHRSI (14)
47.46
Neutral
MACD (12,26)
-0.08
Sell
ADX (14)
17.20
Buy
Williams %R
-19.16
Sell
CCI (14)
22.66
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
48.47
Neutral
ROC
1.23
Buy
Inmune Bio’s (INMB) Relative Strength Index (RSI) is 50.82, creating a Neutral signal.
Inmune Bio’s (INMB) Trend Strength Indicator (ADX) is 17.20, creating a Buy signal.
Inmune Bio’s (INMB) Commodity Channel Index (CCI) is 22.66, creating a Neutral signal.
Inmune Bio’s (INMB) Price Rate of Change (ROC) is 1.23, creating a Buy signal.

FAQ

Is INMB a Buy, Hold, or Sell?
Based on INMB’s technical indicators, INMB is a Hold.
    What is INMB’s RSI (14)?
    INMB’s RSI (14) is 50.82, which suggests INMB is a Neutral.
      What is INMB’s MACD?
      INMB’s MACD is -0.08, which suggests INMB is a Sell.
        What is INMB’s 5-day moving average?
        INMB’s 5-day moving average is 1.53, which suggests INMB is a Buy.
          What is INMB’s 20-day moving average?
          INMB 20-day moving average is 1.58, which suggests INMB is a Buy.
            What is INMB’s 50-day moving average?
            INMB’s 50-day moving average is 1.80, which suggests INMB is a Sell.
              What is INMB’s 200-day moving average?
              INMB’s 200-day moving average is 4.72, which suggests INMB is a Sell.
                What is INMB’s Williams % R (14)?
                INMB’s Williams % R (14) is -19.16, which suggests INMB is a Sell.
                  What is INMB’s CCI (14)?
                  INMB’s CCI (14) is 22.66, which suggests INMB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis